{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T14:03:21Z","timestamp":1771682601312,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100011091","name":"FOD Volksgezondheid, Veiligheid van de Voedselketen en Leefmilieu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011091","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Health Econ Health Policy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40258-025-01011-5","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T16:44:21Z","timestamp":1762533861000},"page":"393-405","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Budget Impact Analysis of Implementing C-Reactive Protein Point-of-Care Testing to Aid Antibiotic Prescribing in Belgian Primary Care"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-2459-9201","authenticated-orcid":false,"given":"Salima","family":"Azahaf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erinn","family":"D\u2019hulster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margo","family":"Van Genechten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thaddee","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tibo","family":"Wynant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Luyten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Y.","family":"Verbakel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"key":"1011_CR1","unstructured":"Federal Public Service Health, Food Chain Safety and Environment. Belgian \u201cOne Health\u201d National Action Plan on the fight against antimicrobial resistance (AMR) 2020\u20132024 [Internet]. Brussels: FPS Health; 2020 [cited 2025 Oct 27]. Available from:https:\/\/www.health.belgium.be\/sites\/default\/files\/uploads\/fields\/fpshealth_theme_file\/en-amr_one_health_national_plan_final_1.pdf."},{"issue":"7","key":"1011_CR2","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1179\/2047773215Y.0000000030","volume":"109","author":"F Prestinaci","year":"2015","unstructured":"Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health. 2015;109(7):309\u201318. https:\/\/doi.org\/10.1179\/2047773215Y.0000000030.","journal-title":"Pathog Glob Health"},{"issue":"10","key":"1011_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.7326\/0003-4819-140-10-200405180-00009","volume":"140","author":"JR Nebeker","year":"2004","unstructured":"Nebeker JR, Barach P, Samore MH. Clarifying adverse drug events: a clinician\u2019s guide to terminology, documentation, and reporting. Ann Intern Med. 2004;140(10):795. https:\/\/doi.org\/10.7326\/0003-4819-140-10-200405180-00009.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1011_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2296-8-15","volume":"8","author":"JW Cals","year":"2007","unstructured":"Cals JW, Hopstaken RM, Butler CC, Hood K, Severens JL, Dinant G-J. Improving management of patients with acute cough by C-reactive protein point of care testing and communication training (IMPAC3T): study protocol of a cluster randomised controlled trial. BMC Fam Pract. 2007;8(1):15. https:\/\/doi.org\/10.1186\/1471-2296-8-15.","journal-title":"BMC Fam Pract"},{"issue":"1","key":"1011_CR5","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1093\/cid\/ciaa667","volume":"72","author":"AL Hersh","year":"2021","unstructured":"Hersh AL, King LM, Shapiro DJ, Hicks LA, Fleming-Dutra KE. Unnecessary antibiotic prescribing in US ambulatory care settings, 2010\u20132015. Clin Infect Dis. 2021;72(1):133\u20137. https:\/\/doi.org\/10.1093\/cid\/ciaa667.","journal-title":"Clin Infect Dis"},{"key":"1011_CR6","unstructured":"De Bont EGPM et al., NHG-Standaard Acuut hoesten (M78). 2024. [Online]. https:\/\/richtlijnen.nhg.org\/standaarden\/acuut-hoesten. Accessed 16 Dec 2024."},{"issue":"1","key":"1011_CR7","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-025036","volume":"9","author":"JY Verbakel","year":"2019","unstructured":"Verbakel JY, et al. Impact of point-of-care C reactive protein in ambulatory care: a systematic review and meta-analysis. BMJ Open. 2019;9(1):e025036. https:\/\/doi.org\/10.1136\/bmjopen-2018-025036.","journal-title":"BMJ Open"},{"key":"1011_CR8","doi-asserted-by":"publisher","unstructured":"Smedemark SA, Aabenhus R, Llor C, Fournaise A, Olsen O, J\u00f8rgensen KJ. Biomarkers as point-of-care tests to guide prescription of antibiotics in people with acute respiratory infections in primary care. (see pp 43-44).  Cochrane Database Syst Rev. 2022;2022(10). https:\/\/doi.org\/10.1002\/14651858.CD010130.pub3.","DOI":"10.1002\/14651858.CD010130.pub3"},{"key":"1011_CR9","unstructured":"AMC. European Centre for Disease Prevention and Control [Internet]. [cited 2025]. https:\/\/qap.ecdc.europa.eu\/public\/extensions\/AMC2_Dashboard\/AMC2_Dashboard.html#eu-consumption-tab. Accessed 2024."},{"key":"1011_CR10","doi-asserted-by":"publisher","unstructured":"Llor C, et al. C-reactive protein point-of-care testing in primary care\u2014broader implementation needed to combat antimicrobial resistance. Front Public Health. 2024;12:1397096. https:\/\/doi.org\/10.3389\/fpubh.2024.1397096.","DOI":"10.3389\/fpubh.2024.1397096"},{"key":"1011_CR11","unstructured":"Hopstaken RM, Broekhuizen BDL, Butler CC, Cals JWL, Dinant GJ, van der Meer V, van den Bruel A, van Boven K, Verheij TJM. Richtlijn Point-of-Care Testing (POCT) in de huisartsenzorg. Utrecht: NHG; 2015."},{"issue":"4","key":"1011_CR12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.3109\/00365513.2015.1006136","volume":"75","author":"MC Minnaard","year":"2015","unstructured":"Minnaard MC, et al. The added diagnostic value of five different C-reactive protein point-of-care test devices in detecting pneumonia in primary care: a nested case-control study. Scand J Clin Lab Investig. 2015;75(4):291\u20135. https:\/\/doi.org\/10.3109\/00365513.2015.1006136.","journal-title":"Scand J Clin Lab Investig"},{"issue":"1","key":"1011_CR13","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s12913-023-09065-8","volume":"23","author":"JE Dewez","year":"2023","unstructured":"Dewez JE, et al. Adoption of C-reactive protein point-of-care tests for the management of acute childhood infections in primary care in the Netherlands and England: a comparative health systems analysis. BMC Health Serv Res. 2023;23(1):191. https:\/\/doi.org\/10.1186\/s12913-023-09065-8.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"1011_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-020-01359-w","volume":"9","author":"S Mortazhejri","year":"2020","unstructured":"Mortazhejri S, et al. Systematic review of patient-oriented interventions to reduce unnecessary use of antibiotics for upper respiratory tract infections. Syst Rev. 2020;9(1):106. https:\/\/doi.org\/10.1186\/s13643-020-01359-w.","journal-title":"Syst Rev"},{"key":"1011_CR15","unstructured":"Cleemput I, Neyt M, Van de Sande S, Thiry N. Belgian guidelines for economic evaluations and budget impact analyses: second edition. Brussels: Belgian Health Care Knowledge Centre (KCE); 2012. (KCE Report 183C)."},{"issue":"2","key":"1011_CR16","doi-asserted-by":"publisher","first-page":"114","DOI":"10.3109\/13814788.2013.828200","volume":"20","author":"N Adriaenssens","year":"2014","unstructured":"Adriaenssens N, Bartholomeeusen S, Ryckebosch P, Coenen S. Quality of antibiotic prescription during office hours and out-of-hours in Flemish primary care, using European quality indicators. Eur J Gen Pract. 2014;20(2):114\u201320. https:\/\/doi.org\/10.3109\/13814788.2013.828200.","journal-title":"Eur J Gen Pract"},{"issue":"4","key":"1011_CR17","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1093\/fampra\/cmw039","volume":"33","author":"MC Minnaard","year":"2016","unstructured":"Minnaard MC, et al. C-reactive protein point-of-care testing and associated antibiotic prescribing. Fam Pract. 2016;33(4):408\u201313. https:\/\/doi.org\/10.1093\/fampra\/cmw039.","journal-title":"Fam Pract"},{"key":"1011_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/fampra\/cmv019","author":"ARJ Dekker","year":"2015","unstructured":"Dekker ARJ, Verheij TJM, van der Velden AW. Inappropriate antibiotic prescription for respiratory tract indications: most prominent in adult patients. Fam Pract. 2015. https:\/\/doi.org\/10.1093\/fampra\/cmv019.","journal-title":"Fam Pract"},{"issue":"1","key":"1011_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/1472-6947-14-48","volume":"14","author":"C Truyers","year":"2014","unstructured":"Truyers C, Goderis G, Dewitte H, vanden Akker M, Buntinx F. The intego database: background, methods and basic results of a Flemish general practice-based continuous morbidity registration project. BMC Med Inform Decis Mak. 2014;14(1):48. https:\/\/doi.org\/10.1186\/1472-6947-14-48.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"2","key":"1011_CR20","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/fampra\/cmx081","volume":"35","author":"TJ Schuijt","year":"2018","unstructured":"Schuijt TJ, Boss DS, Musson REA, Demir AY. Influence of point-of-care C-reactive protein testing on antibiotic prescription habits in primary care in the Netherlands. Fam Pract. 2018;35(2):179\u201385. https:\/\/doi.org\/10.1093\/fampra\/cmx081.","journal-title":"Fam Pract"},{"key":"1011_CR21","doi-asserted-by":"publisher","unstructured":"Spurling GK, Del Mar CB, Dooley L, Foxlee R, Farley R. Delayed antibiotic prescriptions for respiratory infections. Cochrane Database Syst Rev. 2017;(9):CD004417 (see pp 43\u201344). https:\/\/doi.org\/10.1002\/14651858.CD004417.pub5.","DOI":"10.1002\/14651858.CD004417.pub5"},{"key":"1011_CR22","unstructured":"NHS. Amoxicillin: antibiotic to treat bacterial infections [Internet]. [cited 2025]. Available from: https:\/\/www.nhs.uk\/medicines\/amoxicillin\/. Accessed 2024."},{"key":"1011_CR23","unstructured":"FDA [Internet]. FDA Adverse Event Reporting System (FAERS) public dashboard. [cited 2025]. https:\/\/www.fda.gov\/drugs\/questions-and-answers-fdas-adverse-event-reporting-system-faers\/fda-adverse-event-reporting-system-faers-public-dashboard. Accessed 2024."},{"issue":"8","key":"1011_CR24","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s40273-022-01165-3","volume":"40","author":"S van der Pol","year":"2022","unstructured":"van der Pol S, et al. The opportunity of point-of-care diagnostics in general practice: modelling the effects on antimicrobial resistance. Pharmacoeconomics. 2022;40(8):823\u201333. https:\/\/doi.org\/10.1007\/s40273-022-01165-3.","journal-title":"Pharmacoeconomics"},{"key":"1011_CR25","unstructured":"Van der Pol S. Technical manual MERIAM [Internet]. [cited 2025]. https:\/\/umcg-global-health.github.io\/MERIAM\/#443_AMR_forecasts. Accessed 2024."},{"key":"1011_CR26","unstructured":"AMC | European Centre for Disease Prevention and Control [Internet]. [cited 2025]. https:\/\/qap.ecdc.europa.eu\/public\/extensions\/AMC2_Dashboard\/AMC2_Dashboard.html#eu-consumption-tab. Accessed 2024."},{"issue":"10325","key":"1011_CR27","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJL Murray","year":"2022","unstructured":"Murray CJL, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0.","journal-title":"Lancet"},{"key":"1011_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2024.119737","volume":"560","author":"L Van Hoovels","year":"2024","unstructured":"Van Hoovels L, et al. Analytical performance and user-friendliness of four commercially available point-of-care devices for C-reactive protein. Clin Chim Acta. 2024;560:119737. https:\/\/doi.org\/10.1016\/j.cca.2024.119737.","journal-title":"Clin Chim Acta"},{"key":"1011_CR29","unstructured":"Intermutualistisch Agentschap. PROJECT IMA ATLAS. Metadatafiche [Internet]. [cited 2025]. https:\/\/atlas.ima-aim.be\/\/info\/metadataPDF\/METADATA_003_014_NL.pdf. Accessed 2024."},{"key":"1011_CR30","unstructured":"RIZIV [Internet]. De erkende labo\u2019s en hun verstrekkingen. [cited 2025]. https:\/\/www.inami.fgov.be\/nl\/professionals\/verzorgingsinstellingen\/laboratoria\/Paginas\/historiek-erkende-labos-verstrekkingen.aspx. Accessed 2024."},{"key":"1011_CR31","unstructured":"RIZIV. Aantal individuele zorgverleners in 2022. [cited 2025; Accessed 2024]. https:\/\/www.riziv.fgov.be\/nl\/statistieken\/statistieken-geneeskundige-verzorging\/statistieken-2022\/aantal-individuele-zorgverleners-in-2022."},{"key":"1011_CR32","unstructured":"RIZIV [Internet]. NomenSoft. [cited 2025]. https:\/\/webappsa.riziv-inami.fgov.be\/Nomen\/nl\/search. Accessed 2024."},{"key":"1011_CR33","unstructured":"BAPCOC\u2014Belgische gids voor anti-infectieuze behandelingen [Internet]. BCFI. [cited 2025]. https:\/\/www.bcfi.be\/nl\/chapters\/12?frag=8000010. Accessed 2024."},{"key":"1011_CR34","unstructured":"BCFI | BAPCOC Belgian guide for anti-infective treatments in outpatient practice. Specialiteiten [Internet]. [cited 2025]. https:\/\/www.bcfi.be\/nl\/chapters\/4?frag=3343&trade_family=9134. Accessed 2024."},{"key":"1011_CR35","unstructured":"BCFI | BAPCOC Belgian guide for anti-infective treatments in outpatient practice. Folia [Internet]. [cited 2025]. https:\/\/www.bcfi.be\/nl\/articles\/query?number=F27N06A.  Accessed 2024."},{"key":"1011_CR36","unstructured":"BCFI | BAPCOC Belgian guide for anti-infective treatments in outpatient practice. Zoekresultaat cetirizine [Internet]. [cited 2025]. https:\/\/www.bcfi.be\/nl\/keywords\/327?type=substance&tree=1. Accessed 2024."},{"key":"1011_CR37","doi-asserted-by":"publisher","unstructured":"Reigadas E, Bouza E. Economic burden of Clostridium difficile infection in European countries. In: Mastrantonio P, Rupnik M, editors. Clostridium difficile Infection in Europe: A Clinical Casebook. Cham: Springer; 2018. p. 1\u201312. https:\/\/doi.org\/10.1007\/978-3-319-72799-8_1","DOI":"10.1007\/978-3-319-72799-8_1"},{"issue":"2","key":"1011_CR38","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1080\/17843286.2020.1868906","volume":"77","author":"V Van Hoof","year":"2022","unstructured":"Van Hoof V, et al. Organisation and quality monitoring for point-of-care testing (POCT) in Belgium: proposal for an expansion of the legal framework for POCT into primary health care. Acta Clin Belg. 2022;77(2):329\u201336. https:\/\/doi.org\/10.1080\/17843286.2020.1868906.","journal-title":"Acta Clin Belg"},{"key":"1011_CR39","unstructured":"RIZIV. Ge\u00efntegreerde praktijkpremie huisartsgeneeskunde. [cited 2025]. https:\/\/www.riziv.fgov.be\/nl\/professionals\/individuele-zorgverleners\/artsen\/financiele-tegemoetkomingen\/geintegreerde-praktijkpremie. Accessed 2024."},{"key":"1011_CR40","unstructured":"STATBEL. Structure of the Population. [cited 2025]. https:\/\/statbel.fgov.be\/en\/themes\/population\/structure-population#figures.  Accessed 2024."},{"key":"1011_CR41","unstructured":"FPS Social Security. Gezondheidsuitgaven ten laste van huishoudens (SHA). [cited 2025]. https:\/\/socialsecurity.belgium.be\/nl\/cijfers-van-sociale-bescherming\/cijfers-de-kijker\/gezondheidsuitgaven-ten-laste-van-huishoudens-sha. Accessed 2024."},{"key":"1011_CR42","doi-asserted-by":"crossref","unstructured":"Leroy R, De Niel C, Swartenbroekx N, Cleemput I. Proposals for a more effective antibiotic policy in Belgium. Brussels: Belgian Health Care Knowledge Centre (KCE); 2019. (KCE Report 313)","DOI":"10.57598\/R311CS"},{"issue":"6","key":"1011_CR43","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1007\/s12445-017-0168-7","volume":"60","author":"M Minnaard","year":"2017","unstructured":"Minnaard M. De CRP-sneltest bij lageluchtweginfecties. Huisarts Wet. 2017;60(6):268\u201372.","journal-title":"Huisarts Wet"}],"container-title":["Applied Health Economics and Health Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-025-01011-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40258-025-01011-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40258-025-01011-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T13:15:25Z","timestamp":1771679725000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40258-025-01011-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["1011"],"URL":"https:\/\/doi.org\/10.1007\/s40258-025-01011-5","relation":{},"ISSN":["1175-5652","1179-1896"],"issn-type":[{"value":"1175-5652","type":"print"},{"value":"1179-1896","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"21 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The manufacturers and the funding organisation(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the article; or in the decision to submit the article for publication.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The model used in this study was made available to the peer reviewers. Data files supporting the analyses and results are available upon request. For any inquiries, please contact Salima Azahaf: salima.azahaf@kuleuven.be.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data and Code Availability"}},{"value":"There are no other competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"SA, ED, MVG, TD, TW, JL, and JV contributed to the conception of the study and\/or data collection. SA, ED, MVG, JL, and JV contributed to data analysis. SA, ED, and MVG produced figures and tables. SA and MVG wrote the original draft of the manuscript. SA, JL, and JV provided critical revisions. All authors reviewed and approved the final version of the manuscript. The authors take full responsibility for the decision to submit the manuscript for publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Contributions"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication (from Patients\/Participants)"}}]}}